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Abstract
Background: Studying T1- and T2-mapping for discrimination of acute from chronic myocardial infarction (AMI, CMI).
Methods: Eight patients with AMI underwent CMR at 3 T acutely and after >3 months. Imaging techniques included:
T2-weighted imaging, late enhancement (LGE), T2-mapping, native and post-contrast T1-mapping. Myocardial T2- and
T1-relaxation times were determined for every voxel. Abnormal voxels as defined by having T2- and T1-values beyond a
predefined threshold (T2 > 50 ms, native T1 > 1250 ms and post-contrast T1 < 350 ms) were highlighted and compared
with LGE as the reference.
Results: Abnormal T2-relaxation times were present in the voxels with AMI (=> delete acute infarction; unfortunately
this is not possible in your web interface) acute infarction only in half of the subjects. Abnormal T2-values were also
present in subjects with CMI, thereby matching the chronically infarcted territory in some. Abnormal native T1 times
were present in voxels with AMI in 5/8 subjects, but also remote from the infarcted territory in four. In CMI, abnormal
native T1 values corresponded with infarcted voxels, but were also abnormal remote from the infarcted territory. Voxels
with abnormal post-contrast T1-relaxation times agreed well with LGE in AMI and CMI.
Conclusions: In this pilot-study, T2- and T1-mapping with simple thresholds did not facilitate the discrimination of AMI
and CMI.
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Background
Cardiovascular magnetic resonance enables myocardial tis-
sue characterization by combining native and contrast-
enhanced techniques with differences in T2- and T1-
weighting. Native T2-weighted imaging has been reported
to detect myocardial edema [1, 2], and T1-weighted late
Gadolinium enhancement imaging (LGE) has been estab-
lished to show necrosis and fibrosis. Recent studies demon-
strated that the use of these techniques allows the
differentiation of acute from chronic myocardial infarction
(AMI, CMI) [3]. However, there is an ongoing controversial
debate about the technical limitations and the pathophysio-
logic background of conventional T2-weighted edema im-
aging [4, 5]. Recently, myocardial T1- and T2-mapping were
introduced to quantify the T1- and T2-relaxation times,
which may be superior to the semiquantitative or qualita-
tive image assessment used with conventional T2-weighted
imaging [6–8]. For patients with AMI, prolonged
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native T2- and T1-relaxation times as well as decreased
post-contrast T1-relaxation times were reported for the in-
farcted areas [9–12]. In patients with CMI, increased na-
tive and decreased post-contrast T1-relaxation times were
reported [12]. However, whether the utilization of T2- and
T1-mapping helps to differentiate AMI and CMI in the in-
dividual patient has not been examined in detail. We hy-
pothesized that applying T1- and T2-mapping with simple
thresholds based on reference values from healthy con-
trols will discriminate AMI and CMI on an individual pa-
tient basis.
Methods
Study population
Eight male patients (mean age 56 ± 13 years) underwent
CMR within 9 ± 3 days (range 5-14 <space>days) after
acute ST-segment elevation myocardial infarction and in
a chronic state 139 ± 50 days (range 92–210 days) after
the acute event. Repeated troponin measurements were
not performed. But all patients remained clinically with-
out onset of new cardiovascular symptoms or any car-
diovascular event between both CMR scans. Patients’
characteristics are described in Table 1. Note that patient
two and four have the lowest release of myocardial en-
zymes but the lowest ejection fraction. In patient 2, this
is attributable to a preexisting three-vessel disease with
prior inferior infarction. In patient four, left-to-left col-
laterals might have compensated the cellular damage
during LAD-occlusion. The results were compared to
previously published T1- and T2-relaxation times in
healthy controls [8].
CMR examination
All CMR examinations were performed with a 3 T MR
system (Magnetom Verio, Siemens Healthcare, Erlangen,
Germany). The protocol was identical for patients and
healthy controls. An integrated body RF coil was
employed for RF transmission and a 32-channel cardiac
RF coil for signal reception if not otherwise stated. ECG
was used for cardiac gating/triggering.
Cine imaging
Steady-state free-precession (SSFP) 2D cine images were
obtained during repeated breath-holds in three long axes
and in a stack of short axes (SAX) covering the left ven-
tricle (LV) to assess wall motion and for cardiac cham-
ber quantification. Imaging parameters were as reported
recently [8].
T2-weighted imaging
Data were acquired in basal, mid-ventricular, and apical
SAX planes in end-diastole using a breath-hold, black-
blood, T2-weighted triple inversion recovery fast-spin-echo
based technique: Imaging parameters were: repetition
time = 2 × R-R-interval; TE = 43 ms; inversion time for fat
(TIfat) = 170 ms, FOV = (340×255)mm
2, matrix = 256×192,
slice thickness = 10 mm, acquisition voxel size 1.3 × 1.3 ×
10 mm3, BW= 235Hz/px, The integrated body RF coil
was used for signal transmission and reception.
T2-mapping
Data were acquired in basal, mid-ventricular, and apical
SAX planes using a T2-prepared single-shot SSFP tech-
nique [6] as described recently [8]. Three SSFP images
with different T2 preparation times were acquired in
end-diastole within a single breath-hold. Imaging
parameters were: TR = 2.4 ms, TE = 1 ms, FA = 70°,
FOV = (340x278) mm2, matrix = 176×144, slice thick-
ness = 6 mm, acquisition voxel size 1.9 × 1.9 ×
6 mm3, BW = 1093Hz/px, GRAPPA acceleration factor
R = 2. Images were motion corrected and a pixel-wise
myocardial T2-map was generated. The principal ac-
curacy of this technique has been demonstrated in
previous phantom experiments [6].
T1-mapping
Data were acquired in basal, mid- ventricular, and apical
SAX planes before and after administration of 0.2 mmol/
kg i.v. gadobutrol (Gadovist®, Bayer Healthcare Germany).
The acquisition of the post-contrast T1-maps was started
in every examination exactly 10 minutes after gadobutrol
Table 1 Patients’ characteristics at acute presentation
Number 1-, 2-, or 3-Vessel disease Culprit lesion Peak CK [U/l] Peak Troponine T [ng/l] LV-EF [%] LV-EDV-I [ml/cm] LV-M-I [g/cm]
1 2 RD 1026 1656 69 0.8 0.8
2 3 LAD 149 1122 30 1.0 0.9
3 1 LAD 1696 1280 68 1.0 0.9
4 1 LAD 46 834 38 1.2 0.9
5 2 RM 4102 9017 58 1.1 0.9
6 1 RCA 3658 3239 54 1.0 0.6
7 1 RCA 1900 3749 51 1.3 1.3
8 1 RCA 3020 5304 45 1.0 0.8
RD= diagonal branch, LAD = left anterior descending, RM= obtuse marginal branch, RCA = right coronary artery; LV-EF = left ventricular ejection fraction; LV-EDV-I = left
ventricular enddiastolic volume indexed by body height; LV-M-I = left ventricular mass indexed by body height
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administration, ensured by a countdown and always
beginning with the basal slice. Data were obtained in end-
diastole using a cardiac-gated, SSFP-based Modified Look-
Locker Inversion Recovery (MOLLI) technique [7, 8].
Imaging parameters were: TR = 2.6–2.7 ms, TE = 1.0–
1.1 ms, FA = 35°, FOV = (270 × 360) mm2, matrix = 156 ×
208 to 168 × 224, slice thickness = 6 mm, acquisition voxel
size 1.6–1.7 × 1.6–1.7 × 6 mm3, BW= 1045-1028Hz/px,
GRAPPA acceleration factor 2. The hypersec adiabatic in-
version pulse achieved an inversion factor of about -0.925.
To generate a pixel-wise myocardial T1-map, single-shot
SSFP images were acquired at different inversion times
(pattern 3-3-5) and registered prior to a non-linear least-
square curve fitting. The principal accuracy of this
technique has been demonstrated in previous phantom
experiments [7]. The heart rate of each subject during the
MOLLI acquisition in the acute and chronic state was as
follows: patient 1:59/62 beats per minute (bpm); patient 2:
83/62 bpm; patient 3: 56/55 bpm; patient 4: 51/51 bpm;
patient 5: 77/65 bpm; patient 6: 62/62 bpm; patient 7: 51/
50 bpm; patient 8: 57/66 bpm.
LGE imaging (LGE)
LGE imaging was performed 15 min after the administra-
tion of gadobutrol in the same planes as SSFP CINE im-
aging using a segmented inversion-recovery gradient-echo
sequence. Imaging settings were as reported recently, with
an acquisition voxel size 1.4 × 1.6 × 6 mm3 [8].
Image analysis
Defining the myocardium within the maps was done
using CMR42 (Circle Cardiovascular Imaging, Calgary,
Canada) as previously described [8]. Much attention was
invested to manually draw the endocardial and epicardial
contours as accurate as possible to omit the inclusion of
blood or epicardial fat.
Based on the 95 % tolerance interval of the T2- and T1-
relaxation times from a previous study in healthy controls
[8], thresholds that discriminate normal from abnormal
T1 and T2 were defined. The cut-off for abnormal T2-
times was >50 ms, native T1 > 1250 ms and post-contrast
T1 < 350 ms. All myocardial pixels that were abnormal
based on these thresholds were automatically highlighted
in color in the corresponding map. The distribution of ab-
normal pixels was correlated with the LGE, which was
regarded as the reference for the localization and extent of
the infarct.
Phantom experiments
Phantom experiments were done to evaluate the accur-
acy of the T2- and T1-mapping method, using the same
MR scanner and coil as for the in-vivo exams. An agar-
based phantom representing a range of T1 and T2 times
was used. The T1-values were verified using an inversion
recovery sequence with acquisition matrix 256x256, TR
15 s, 1 line/inversion, 90° FLASH readout, T1 range
200 ms–1090 ms. T1 values were calculated using a
non-linear least square three-parameter fit. The T2-
values were verified using a multi-echo spin echo
(MESE) approach with matrix 256×256, TR 15 s, 1 seg-
ment, T2-range 16–235 ms. T2 values were calculated
using a mono-exponential least square fit. For compari-
son, the T2- and T1-mappings technique as described for
the in-vivo-measurements were applied. All phantom
studies were performed with a simulated heart rate of 60
beats per minute. The signal-to-noise ratio (SNR) was
estimated as the signal intensity from a manually drawn
region of interest within the corresponding compart-
ment of the phantom and the standard deviation of the
signal intensity from a region of interest in the back-
ground. For T1, the last image of the series was used, for
T2 the first.
Results
Phantom experiments
The results of the phantom experiments are shown in
Table 2. They show that the applied mapping techniques
provide estimates of the T1- and T2-relaxation times
close to the reference technique, with MOLLI underesti-
mating the T1-times. This finding is in concordance with
previous studies that tested the same techniques in
phantom experiments [6, 7].
In-vivo-measurements
All patients had evidence of AMI using LGE and T2-
weighted imaging during the initial scan. Figure 1 provides
images of the various imaging techniques for all subjects.
Note that patient #2 had an old inferior infarction (red
asterisk) but actually presented with LAD occlusion.
Table 2 Relaxation times (in ms and ± SD) and estimates of the
signal-to-noise ratio (SNR) of the phantom experiments
Reference T2 Measured T2 SNR estimate
39 39 ± 3 1412.4
58 65 ± 9 1360.6
83 77 ± 8 2386.9
Reference T1 Measured T1 SNR estimate
286 250 ± 14 571.4
520 473 ± 10 649.8
630 590 ± 14 478.9
925 880 ± 41 1106.5
1090 1062 ± 9 1370.5
The reference T2 was acquired with multi-echo spin echo, the reference T1
with inversion recovery. The measured T2 and T1 is based on the T2- and
T1-mapping as described for the in-vivo-measurements. The estimate of the
SNR stems from the first image of the T2-series and the last of the T1-series
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Figure 2a and b provides the T2- and T1-maps for each
patient with all myocardial pixels that were beyond the
predefined threshold highlighted in color. The absolute
T2- and T1-relaxation times for every subject and every
myocardial segment are given in Table 3.
Only in half of the subjects with AMI, abnormal T2-re-
laxation times corresponded well with the infarcted pixels
as defined by LGE [subjects 1–3, 6]. In the others [subjects
4, 5, 7, 8], pixels with T2-values higher than the normal
range were present, but did not match with the infarcted
territory as defined clinically and by LGE. In CMI (where
no increase of the T2-relaxation time was expected), pixels
with T2-values higher than the normal range were present
in all subjects. In some of them, these pixels matched with
the chronically infarcted territory [subjects 1–3, 6].
Similarly, abnormal native T1 times corresponded with
acutely infarcted pixels in five out of eight subjects
[subjects 1, 3, 6–8] in AMI, but were also present remote
from the infarcted territory [subjects 4–6, 8]. In CMI,
again abnormal native T1 values corresponded with in-
farcted pixels in most of the subjects [subjects 1–3, 5–8],
but native T1 vales were also abnormal remote from the
Fig. 1 Representative images obtained with T2-weighted imaging, late enhancement (LGE), T2-map, native T1-map and post-contrast T1-map for
each patient. The order of the patients corresponds to Table 1. The red arrows in the LGE images highlight the infarct region. Note that patient
#2 had an old inferior infarction (red asterisk) but actually presented with LAD occlusion. Patient five had microvascular obstruction with
hemorrhage (white arrow)
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infarcted territory [subjects 3, 4, 6–8]. Pixels with abnor-
mal post-contrast T1-relaxation times matched very well
with LGE in all subjects both in AMI and CMI.
Discussion
Several reports described differences of the T1- and T2-
relaxation times between infarcted myocardial segments
and remote myocardium [10, 11]. It seems easy to repro-
duce areas of myocardial infarction using T2- or T1-maps
if the localization of myocardial infarction is known. How-
ever, if the investigator is blinded to any clinical informa-
tion, the discrimination of normal from abnormal
myocardium as well as acutely from chronically injured
myocardium solely based on T2- and T1-maps is challen-
ging, as demonstrated in the present case series.
The observed distribution of abnormal and normal re-
laxation times did not match closely with the extent of
the myocardial lesion as defined by LGE, particularly in
the T2-maps and the native T1-maps. In CMI, pixels with
elevated T2-value that would indicate edema appeared in
the myocardium. And both in AMI and CMI, pixels with
abnormal T1- and T2-values appeared also in the remote
myocardium, which is supposed to have values widely
within the normal range.
This mismatch between the results of the thresholding
and the expected distribution of T2- and T1-relaxation
Fig. 2 a and b. Thresholds that discriminate normal from abnormal T1 and T2 relaxation times for every myocardial pixel were defined based on
reference T2-and T1-values from healthy controls. These thresholds were applied on the T2- and T1-maps so that all abnormal pixels in the
myocardium (between the red and green contour) that were outside the normal range became highlighted in a color (blue in T2-map, brown in
T1-maps). The red arrows in the LGE images highlight the infarct region. Note that patient #2 had an old inferior infarction (red asterisk) but
actually presented with LAD occlusion. Patient 5 had microvascular obstruction with hemorrhage (white arrow). a = subjects 1-4; b = subjects 5-8
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Table 3 The T2-and T1-relaxation times for each patient (#1-8) and each myocardial segment (Sg. 1-16)
# Map Time Sg. 1 Sg. 2 Sg. 3 Sg. 4 Sg. 5 Sg. 6 Sg. 7 Sg. 8 Sg. 9 Sg. 10 Sg. 11 Sg. 12 Sg. 13 Sg. 14 Sg. 15 Sg. 16
1 T2 AMI 58.5 49.9 46.4 49.4 45.5 43.2 69.1 47.4 47.0 47.3 44.8 52.9 46.0 47.7 50.5 60.9
CMI 48.7 47.9 49.7 46.8 46.0 46.0 53.4 49.7 49.7 50.1 49.6 48.1 48.2 51.8 50.1 46.3
Native T1 AMI 1353.5 1216.2 1168.3 1188.4 1090.2 1111.0 1393.9 1205.9 1177.5 1137.8 1127.8 1282.2 - - - -
CMI 1387.8 1223.3 1182.1 1181.1 1181.2 1106.7 1412.7 1180.3 1162.7 1074.9 1115.9 1274.3 1243.1 1247.6 1166.0 1232.4
Post-cm T1 AMI 290.8 368.7 419.0 406.1 414.1 414.4 231.2 364.8 404.5 404.4 413.4 413.4 318.8 364.6 398.7 382.0
CMI 430.4 359.8 414.1 416.1 414.1 437.8 236.3 369.8 366.1 444.7 391.1 326.5 346.9 366.9 416.7 417.7
2 T2 AMI 43.9 45.0 42.4 - - 43.0 51.0 55.3 46.4 50.6 44.9 46.9 52.3 55.3 49.5 51.3
CMI 51.2 42.8 66.8 63.7 50.1 48.4 48.8 47.9 55.6 55.5 42.8 43.1 46.3 50.1 49.3 44.3
Native T1 AMI 1122.0 1134.3 1280.7 - - 1076.3 1214.8 1288.5 1200.6 1056.6 1075.7 1158.8 1253.1 1327.7 1246.3 1140.8
CMI 1059.3 1156.2 1383.4 1364.8 1235.9 1069.6 1059.7 1156.2 1383.4 1364.8 1235.9 1069.9 1196.9 1239.7 1146.4 1155.8
Post-cm T1 AMI 423.6 415.0 341.6 374.7 280.4 431.8 360.2 341.0 378.4 251.0 423.7 398.5 351.9 346.9 376.7 406.5
CMI 416.2 403.9 285.3 289.4 324.6 426.4 328.4 337.4 382.7 306.1 451.3 429.0 379.7 365.9 442.9 436.9
3 T2 AMI 51.1 44.4 44.9 45.2 44.6 43.3 52.8 45.2 43.8 42.4 40.3 43.7 57.4 62.7 45.9 43.9
CMI 49.9 42.1 44.1 43.9 44.1 44.2 49.9 43.2 43.1 42.1 42.6 41.1 45.7 48.4 43.7 44.3
Native T1 AMI 1244.2 1144.2 1135.5 1176.8 1119.9 1129.3 1217.4 1185.6 1174.8 1168.0 1139.0 1170.7 1239.0 1444.0 1213.3 1212.6
CMI 1160.0 1134.0 1117.8 - - - 1300.0 1141.5 1152.0 1216.5 1123.4 1184.6 1253.0 1250.6 1204.9 1182.8
Post-cm T1 AMI 409.6 468.6 471.8 475.7 458.6 458.4 413.7 383,0 441.7 492.3 463.4 462.9 411.2 333.7 467.2 460.3
CMI 403.9 421.8 419.1 440.8 - 429.4 362.4 422.0 445.2 438.4 450.5 433.0 348.0 349.4 436.8 416.9
4 T2 AMI 56.5 58.0 51.8 50.5 49.6 46.5 - 62.4 58.7 53.5 49.6 53.5 61.5 57.0 56.9 60.2
CMI 51.7 56.9 61.4 53.5 54.1 49.5 57.0 53.8 54.8 53.8 51.1 54.7 53.7 52.7 54.3 51.6
Native T1 AMI 1326.1 1344.8 1271.8 1184.9 1272.8 1246.7 1370.8 1334.8 1327.6 1193.3 - 1215.9 1388.5 1473.2 1304.5 1155.1
CMI 1171.9 1230.0 1364.6 1284.5 1249.3 1102.7 1224.9 1269.1 1278.4 1199.9 1186.8 1233.2 1236.9 1278.9 1241.6 1184.5
Post-cm T1 AMI - 337.5 383.8 394.0 444.4 418.4 - 327.0 394.9 423.5 417.7 379.6 329.3 315.9 390.6 412.3
CMI - 310.1 362.3 461.1 456.9 421.5 369.3 310.1 362.3 451.3 455.5 421.5 372.8 322.7 430.1 411.9
5 T2 AMI 45.7 45.0 51.5 51.2 56.7 55.2 48.2 44.5 50.3 48.9 58.1 53.5 52.7 47.0 47.2 57.2
CMI 45.0 44.4 48.0 47.7 47.7 48.4 55.5 43.2 43.1 52.9 47.0 48.5 47.2 50.2 48.6 44.6
Native T1 AMI 1124.3 1206.7 1195.1 1207.0 1205.9 1128.9 1060.3 1138.6 1169.2 1179.3 1199.7 1158.1 1098.9 1168.6 1201.4 1305.3
CMI - - 1202.1 1190.3 1225.7 1211.2 1138.6 1139.2 1175.5 1368.9 1276.1 1205.1 1148.9 1148.8 - 1212.1
Post-cm T1 AMI 484.1 464.7 465.3 482.4 391.8 387.0 473.4 489.3 485.8 497.0 405.2 395.4 436.8 456.8 513.0 415.3
CMI 326.9 332.1 332.8 333.4 275.9 228.8 489.3 456.3 468.8 483.1 379.7 330.0 441.7 449.7 490.0 448.7
6 T2 AMI 46.3 45.2 47.5 52.4 56.5 54.5 48.2 46.6 47.1 51.0 59.5 50.4 44.6 48.4 64.7 55.8
CMI 46.5 46.2 49.5 49.2 57.7 51.1 48.1 44.0 48.8 53.1 56.8 48.7 48.1 53.1 56.8 48.7
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Table 3 The T2-and T1-relaxation times for each patient (#1-8) and each myocardial segment (Sg. 1-16) (Continued)
Native T1 AMI 1169.3 1242.5 1228.4 - 1406.4 1376.2 1224.6 1230.6 1257.8 1269.2 1350.0 1379.3 1160.4 1200.0 1413.6 1359.2
CMI 1356.9 1247.2 1219.7 1205.7 1332.1 1430.5 - - - - - - 1146.1 1178.7 1264.5 1300.7
Post-cm T1 AMI 474.0 474.0 474.2 447.9 334.9 356.7 485.1 432.3 465.8 370.5 346.1 477.9 480.0 471.8 392.2 428.8
CMI 334.3 370.5 360.7 359.0 303.6 246.7 327.2 383.7 395.6 294.1 303.1 379.2 402.2 406.4 380.5 276.5
7 T2 AMI 51.7 55.4 73.7 77.3 55.3 54.5 51.1 57.2 76.6 79.9 52.0 52.6 - - - -
CMI 48.2 49.0 48.5 56.8 - 46.7 51.1 51.6 61.9 55.4 50.6 49.7 48.1 50.9 56.3 45.4
Native T1 AMI 1202.6 1333.5 1423.4 1539.3 1328.1 1216.3 1120.2 1246.5 1522.5 1474.8 1214.9 1186.9 - - - -
CMI 1183.5 1234.8 1326.9 1395.0 1216.2 1248.2 1158.1 1245.3 1334.1 1298.4 - 1207.3 1198.3 1254.1 1354.8 -
Post-cm T1 AMI 517.1 484.0 329.7 289.8 463.3 511.3 527.3 485.6 342.3 399.0 523.1 518.8 - - - -
CMI 480.0 463.6 342.0 280.8 436.7 471.2 492.0 462.0 426.9 336.1 - 485.7 491.9 461.9 332.9 483.2
8 T2 AMI 51.2 53.4 63.8 58.3 57.1 51.8 53.0 51.5 66.9 63.9 58.8 54.7 55.1 54.5 62.4 57.6
CMI 50.3 53.6 56.0 54.7 46.4 49.3 47.8 49.4 59.1 61.8 50.8 47.8 48.9 50.3 59.1 48.6
Native T1 AMI 1182.4 1196.6 1338.9 1402.0 1329.1 1194.3 1157.9 1216.7 1396.3 1383.0 1268.0 1224.3 1207.2 1279.9 1500.1 1296.4
CMI 1247.9 1236.2 1299.9 1291.7 1229.7 1228.7 1184.6 1190.6 1311.3 1350.4 1253.1 1246.0 1215.2 1241.6 1346.4 1316.8
Post-cm T1 AMI 465.5 441.5 374.6 331.4 386.7 457.2 434.6 423.8 367.5 314.7 411.0 435.6 424.4 414.8 331.5 429.8
CMI 492.2 503.4 505.4 350.5 386.5 525.4 512.3 547.9 515.5 385.6 551.5 558.6 509.3 547.7 480.2 541.0
The myocardial segments that were affected by myocardial infarction based on the LGE images are in Bold
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times within the myocardium may be attributed to sev-
eral factors:
i.) A challenge of this mapping approach is the inter-
individual scatter of myocardial T2- and T1-relaxation
times that can be large in relation to the small
difference between normal and abnormal
myocardium [8]: The normal T1-value in healthy
controls in the midventricular portion of the LV was
reported to range from 1005 ms to 1296 ms at our
institution and other sites report mean values of 1169
± 73 ms mixed standard deviation [8, 13]. On the
other hand, some authors reported a mean native T1-
value of 1257 ± 97 ms for acutely infarcted segments
compared to 1196 ± 56 ms for normal unaffected
segments in the same subject [10]. Similarly, the
normal T2-values in healthy controls ranged from 38
to 59 ms at 3 T and 46 to 69 ms in a study at 1.5 T
[8, 14]. On the other hand, a T2 value of 60 ms has
been reported as an adequate cutoff to determine
active myocarditis [15]. Therefore, using one simple
threshold based on normal values with a large scatter
is probably imperfect for the individual subject. For
example, in a person with T1-values in the lower
range of the reference, the T1-values may still be
within the normal range even after an infarct-related
increase of 150 ms. This concept certainly needs
further analysis in studies with larger samples. The
large normal range is presumably attributable to
physiological variations as well as to many other
influencing factors like a potential heart-rate depend-
ency of some acquisition methods and partial volume
effects as outlined below. A detailed description of
factors influencing the precision and accuracy of T1-
measurements is available elsewhere [16]. In future,
new ways of image post-processing may correct for
some of these influencing factors, as recently demon-
strated by Xanthis et al. [17]. An alternative approach
to analyze maps - instead of defining thresholds based
on the relaxation time - maybe the analysis based on
the signal intensity. Kali et al. recently studied the use
of native T1-maps in CMI. CMI was defined as using
the mean ±5 standard deviation criterion relative to
the respective reference regions of interest. Using this
approach, native T1-maps and LGE images showed a
close agreement to determine regions with CMI [18].
ii.)Another aspect is the influence of partial volume.
Pixels that include blood or epicardial fat quickly
reach pathologic T2- and T1-values and are
misleadingly classified as abnormal. Even though all
attempts were made to minimize this error by
drawing the contours exactly within the compact
myocardium, a significant influence of partial
volume effects still has to be assumed. Higher spatial
resolution may solve this problem in the future, and
single pixels with abnormal values located at the
edge of the myocardium have to be interpreted with
caution.
iii.)In this case series microvascular obstruction was
detected by LGE images in only one subject,
therefore it does not explain the frequent mismatch
between the thresholding and the expected
distribution of abnormal T2- and T1-values. But
generally, both T2- and T1-maps have been reported
to be affected by microvascular obstruction leading
to “hypoenhancement” within the “hyperenhanced”
acute infarction [19]. Therefore, if large enough,
microvascular obstruction may contribute to an
inaccurate determination of the infarct area on T2-
and T1-maps.
Limitations
The heart rate can influence T1-values by affecting the
relaxation between the MOLLI segments. In this study,
the heart rate ranged from 50 to 83 bpm. Together with
the small sample size (n = 8), these may be the major
factors for data overlapping. Using a different mapping
sequences with less heart-rate sensitivity, such as the
5(3 s)3 MOLLI variant, could have resulted in an im-
proved performance of T1-mapping [16]. A limitation of
the phantom experiments is that SNR has only been es-
timated, because no correction for multi-element coils
has been performed [20, 21].
Conclusions
This pilot study demonstrated that T2- and T1-maps
with a simple threshold-based analysis did not facilitate
the detection of myocardial infarction and the discrimin-
ation of AMI and CMI in the individual patient. Despite
all enthusiasm for myocardial mapping, improvements
in the technology as well as additional concepts for dis-
criminating normal from abnormal myocardium may be
necessary.
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